Matches in Wikidata for { <http://www.wikidata.org/entity/Q92667531> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- Q92667531 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92667531 description "scientific article published on 16 August 2019" @default.
- Q92667531 description "wetenschappelijk artikel" @default.
- Q92667531 description "наукова стаття, опублікована 16 серпня 2019" @default.
- Q92667531 name "First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors" @default.
- Q92667531 name "First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors" @default.
- Q92667531 type Item @default.
- Q92667531 label "First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors" @default.
- Q92667531 label "First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors" @default.
- Q92667531 prefLabel "First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors" @default.
- Q92667531 prefLabel "First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors" @default.
- Q92667531 P1433 Q92667531-881ACF1E-BB62-4315-B279-7062599BD6F6 @default.
- Q92667531 P1476 Q92667531-FF2A04E1-2687-49CF-BA53-1A5EBDD88335 @default.
- Q92667531 P2093 Q92667531-1262E34D-B5DD-46D8-90A4-EBCB2DBB052C @default.
- Q92667531 P2093 Q92667531-1477CFCD-DD25-42DC-AEC7-460FF2CAACB6 @default.
- Q92667531 P2093 Q92667531-1CFF1381-02CD-4EE4-8995-638A9B0E5E95 @default.
- Q92667531 P2093 Q92667531-273912D8-35C2-4C2C-AE60-27D4CB68F4B5 @default.
- Q92667531 P2093 Q92667531-2D14B16B-C7AB-407D-9ACC-105CFF1CCC91 @default.
- Q92667531 P2093 Q92667531-30741518-0B0B-41FE-9DD9-002DC21C153B @default.
- Q92667531 P2093 Q92667531-8357A86B-BAAD-406E-B210-3A3E1F5A0987 @default.
- Q92667531 P2093 Q92667531-B8B2620F-0C70-4957-864A-ABB44F3BDB1B @default.
- Q92667531 P2093 Q92667531-BDCDB9FC-AC40-4837-920D-D9EAD1195424 @default.
- Q92667531 P2093 Q92667531-C058496F-623A-487E-BE21-123CA220E473 @default.
- Q92667531 P2093 Q92667531-E7C7D494-F037-46CE-A6DC-711A59605EAA @default.
- Q92667531 P2093 Q92667531-EE86E28A-7B3C-4E11-9C89-D1800C4DC9BC @default.
- Q92667531 P2093 Q92667531-FCB7B6DA-1B0C-4A19-8CF0-96DB9C1CEB89 @default.
- Q92667531 P304 Q92667531-E4C5FB58-1E7F-4B2B-BE4D-414F3A58BCED @default.
- Q92667531 P31 Q92667531-B0055CAB-DC51-4941-BA66-965ADD3A8650 @default.
- Q92667531 P356 Q92667531-09EE084E-DBB4-4A95-900D-3F7D99F8BECC @default.
- Q92667531 P433 Q92667531-CF0B74F1-FE1D-4565-8E3F-6938CCC1EC03 @default.
- Q92667531 P478 Q92667531-04D0D47D-27A5-48ED-9CA1-05298815F150 @default.
- Q92667531 P50 Q92667531-05EA8F0B-CF62-4E7C-92F5-EC22FAF8352F @default.
- Q92667531 P50 Q92667531-2E5FE5A7-13C4-40A9-A05E-642C7EA04034 @default.
- Q92667531 P577 Q92667531-5EB9981E-99E0-4DFF-9529-486042DE7512 @default.
- Q92667531 P698 Q92667531-5262DD0E-884E-4526-9FA8-7C294E126245 @default.
- Q92667531 P356 1078-0432.CCR-19-0578 @default.
- Q92667531 P698 31420359 @default.
- Q92667531 P1433 Q332253 @default.
- Q92667531 P1476 "First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors" @default.
- Q92667531 P2093 "Anjla Sood" @default.
- Q92667531 P2093 "Beibei Hu" @default.
- Q92667531 P2093 "Bert H O'Neil" @default.
- Q92667531 P2093 "Dimple Modi" @default.
- Q92667531 P2093 "Jasgit C Sachdev" @default.
- Q92667531 P2093 "Jessica E Hutti" @default.
- Q92667531 P2093 "Johannes Wolff" @default.
- Q92667531 P2093 "Kevin J Freise" @default.
- Q92667531 P2093 "Minal Barve" @default.
- Q92667531 P2093 "Patricia LoRusso" @default.
- Q92667531 P2093 "Primo N Lara" @default.
- Q92667531 P2093 "Russell Szmulewitz" @default.
- Q92667531 P2093 "Xiaotian Chen" @default.
- Q92667531 P304 "6309-6319" @default.
- Q92667531 P31 Q13442814 @default.
- Q92667531 P356 "10.1158/1078-0432.CCR-19-0578" @default.
- Q92667531 P433 "21" @default.
- Q92667531 P478 "25" @default.
- Q92667531 P50 Q56890176 @default.
- Q92667531 P50 Q88175695 @default.
- Q92667531 P577 "2019-08-16T00:00:00Z" @default.
- Q92667531 P698 "31420359" @default.